India's Indegene climbs; Kotak raises fair value

Shares of Indegene INEG.NS gain 1.4% to 591.6 rupees; stock rose as much as 3.5% on the day

Brokerage Kotak Institutional Equities hikes fair value by 6% to 700 rupees, a Street-high; keeps "buy" rating

Says growth recovery for FY26 is on track, tariffs uncertainties have not impacted demand significantly

INEG provides digital services in the biopharma industry; major chunk of its revenue comes from North America

Kotak expects co to deliver double-digit revenue growth in FY26, backed by strong deals pipeline, better industry outlook and lower client-specific headwinds

Stock rated "hold" on avg, median PT is 610 rupees - data compiled by LSEG

INEG down ~2% year-to-date